12 Health Care Stocks Moving In Wednesday's Intraday Session
Portfolio Pulse from Benzinga Insights
The article highlights significant intraday movements in health care stocks on Wednesday. Notable gainers include IGM Biosciences (IGMS), Akso Health Group (AHG), MultiPlan (MPLN), Cyclerion Therapeutics (CYCN), TransCode Therapeutics (RNAZ), and Indaptus Therapeutics (INDP). On the losing side, Biodexa Pharmaceuticals (BDRX), Oragenics (OGEN), LifeStance Health Group (LFST), Mustang Bio (MBIO), Eagle Pharmaceuticals (EGRX), and GT Biopharma (GTBP) saw substantial declines.
May 22, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Akso Health Group stock moved upwards by 21.96% to $1.05, with a market cap of $153.8 million.
The substantial price increase indicates positive market sentiment or favorable developments for the company.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Cyclerion Therapeutics shares rose 14.61% to $2.98, with a market cap of $7.4 million.
The price increase indicates positive market reaction, possibly due to favorable news or developments.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
POSITIVE IMPACT
IGM Biosciences shares increased by 36.6% to $11.49, with a market cap of $678.1 million.
The significant price increase suggests strong investor confidence or positive news related to the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Indaptus Therapeutics shares moved upwards by 11.91% to $2.63, with a market cap of $22.4 million.
The price increase indicates positive market sentiment or favorable developments for the company.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
POSITIVE IMPACT
MultiPlan shares rose 18.57% to $0.64, with a market cap of $415.4 million.
The notable price increase suggests positive investor sentiment or news impacting the company favorably.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100
POSITIVE IMPACT
TransCode Therapeutics shares increased by 12.79% to $1.41, with a market cap of $9.3 million.
The price increase suggests positive investor sentiment or favorable news for the company.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
Biodexa Pharmaceuticals shares declined by 41.2% to $1.37, with a market cap of $7.6 million.
The significant price decline suggests negative news or developments impacting the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
NEGATIVE IMPACT
Eagle Pharmaceuticals stock fell 16.71% to $3.64, with a market cap of $47.1 million.
The price decline suggests negative investor sentiment or unfavorable news for the company.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
GT Biopharma stock decreased by 16.08% to $4.7, with a market cap of $6.6 million.
The price decline indicates negative market sentiment or unfavorable developments for the company.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 100
NEGATIVE IMPACT
LifeStance Health Group shares decreased by 19.42% to $6.03, with a market cap of $2.3 billion.
The notable price decline suggests negative investor sentiment or unfavorable developments for the company.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
NEGATIVE IMPACT
Mustang Bio shares decreased by 17.1% to $0.26, with a market cap of $3.2 million.
The price decline indicates negative market reaction, possibly due to unfavorable news or developments.
CONFIDENCE 80
IMPORTANCE 65
RELEVANCE 100
NEGATIVE IMPACT
Oragenics stock fell 36.85% to $1.92, with a market cap of $8.6 million.
The substantial price decline indicates negative market sentiment or unfavorable news for the company.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100